These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 23629540)

  • 1. Circulating microRNAs as novel biomarkers for diabetes mellitus.
    Guay C; Regazzi R
    Nat Rev Endocrinol; 2013 Sep; 9(9):513-21. PubMed ID: 23629540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study.
    Seyhan AA; Nunez Lopez YO; Xie H; Yi F; Mathews C; Pasarica M; Pratley RE
    Sci Rep; 2016 Aug; 6():31479. PubMed ID: 27558530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development.
    Latreille M; Herrmanns K; Renwick N; Tuschl T; Malecki MT; McCarthy MI; Owen KR; Rülicke T; Stoffel M
    J Mol Med (Berl); 2015 Oct; 93(10):1159-69. PubMed ID: 26013143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNAs in Pancreatic β-Cell Physiology.
    Özcan S
    Adv Exp Med Biol; 2015; 887():101-17. PubMed ID: 26662988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs: early prognostic biomarkers for Type 2 diabetes mellitus?
    Bhatia P; Raina S; Chugh J; Sharma S
    Biomark Med; 2015; 9(10):1025-40. PubMed ID: 26441333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus Patients.
    Elemam NM; Hasswan H; Aljaibeji H; Sulaiman N
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes.
    Zheng Y; Wang Z; Zhou Z
    Cell Mol Immunol; 2017 Jun; 14(6):488-496. PubMed ID: 28317889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The small RNA miR-375 - a pancreatic islet abundant miRNA with multiple roles in endocrine beta cell function.
    Eliasson L
    Mol Cell Endocrinol; 2017 Nov; 456():95-101. PubMed ID: 28254488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are extracellular microRNAs involved in type 2 diabetes and related pathologies?
    Rome S
    Clin Biochem; 2013 Jul; 46(10-11):937-45. PubMed ID: 23499584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating RNAs as predictive markers for the progression of type 2 diabetes.
    Ghai V; Baxter D; Wu X; Kim TK; Kuusisto J; Laakso M; Connolly T; Li Y; Andrade-Gordon P; Wang K
    J Cell Mol Med; 2019 Apr; 23(4):2753-2768. PubMed ID: 30734465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction.
    Guay C; Jacovetti C; Nesca V; Motterle A; Tugay K; Regazzi R
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():12-21. PubMed ID: 22928560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease.
    Amr KS; Abdelmawgoud H; Ali ZY; Shehata S; Raslan HM
    Br J Biomed Sci; 2018 Apr; 75(2):82-87. PubMed ID: 29452547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of microRNA in pancreatic beta cell function.
    Brozzi F
    Int Rev Cell Mol Biol; 2021; 359():257-286. PubMed ID: 33832650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes.
    Mirra P; Raciti GA; Nigro C; Fiory F; D'Esposito V; Formisano P; Beguinot F; Miele C
    Epigenomics; 2015; 7(4):653-67. PubMed ID: 26111035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of MicroRNAs in Type 2 Diabetes and Associated Vascular Complications.
    Banerjee J; Nema V; Dhas Y; Mishra N
    Biochimie; 2017 Aug; 139():9-19. PubMed ID: 28487136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum microRNA profiling and bioinformatics analysis of patients with type 2 diabetes mellitus in a Chinese population.
    Yang ZM; Chen LH; Hong M; Chen YY; Yang XR; Tang SM; Yuan QF; Chen WW
    Mol Med Rep; 2017 Apr; 15(4):2143-2153. PubMed ID: 28260062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Landscape of microRNAs in βCell: Between Phenotype Maintenance and Protection.
    Grieco GE; Brusco N; Licata G; Fignani D; Formichi C; Nigi L; Sebastiani G; Dotta F
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MicroRNAs: circulating biomarkers in type 2 Diabetes Mellitus and physical exercise].
    Gómez-Banoy N; Mockus I
    Rev Med Chil; 2016 Mar; 144(3):355-63. PubMed ID: 27299822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs: markers of β-cell stress and autoimmunity.
    Dotta F; Ventriglia G; Snowhite IV; Pugliese A
    Curr Opin Endocrinol Diabetes Obes; 2018 Aug; 25(4):237-245. PubMed ID: 29846238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two Novel MicroRNA Biomarkers Related to β-Cell Damage and Their Potential Values for Early Diagnosis of Type 1 Diabetes.
    Liu L; Yan J; Xu H; Zhu Y; Liang H; Pan W; Yao B; Han X; Ye J; Weng J
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1320-1329. PubMed ID: 29370422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.